DRTS Alpha Tau Medical Ltd.
Healthcare$10.37+3.29%ClosedMarket Cap: $912.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
12.99
P/S
0.00
EV/EBITDA
-19.27
DCF Value
$-0.02
FCF Yield
-3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-73.2%
ROA
-52.3%
ROIC
-46.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-13.3M | $-22.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-12.6M | $-12.1M | $— | — |
| FY null | $0.00 | -Infinity% | $-42.3M | $-42.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-10.7M | $-11.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.6M | $-10.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.3M | $-8.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-10.3M | $-9.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-36.0M | $-31.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.3M | $-6.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.1M | $-7.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.4M | $-8.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-9.9M | $-7.4M | $-0.11 | — |